J1I-MC-GZBK: A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants with Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial (TRIUMPH-2)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503658-11-00

Acronym

J1I-MC-GZBK

Enrollment

235

Registered

2023-08-21

Start date

2023-08-31

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Type 2 Diabetes

Brief summary

Percent Change from Baseline in Body Weight

Interventions

DRUGPlacebo injection

DRUGRetatrutide

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Percent Change from Baseline in Body Weight	—

Countries

Romania, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026